Receptor Tyrosine Kinases as Candidate Prognostic Biomarkers and Therapeutic Targets in Meningioma
Meningioma (MGM) is the most common type of intracranial tumor in adults. The validation of novel prognostic biomarkers to better inform tumor stratification and clinical prognosis is urgently needed. Many molecular and cellular alterations have been described in MGM tumors over the past few years,...
Guardado en:
Autores principales: | Rafael Roesler, Barbara Kunzler Souza, Gustavo R. Isolan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cf5a5bd28c35447baf38e34d1f7122fc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Impact of HER2 receptor status on axillary nodal burden in patients with non-luminal A invasive ductal breast carcinoma
por: Kustic,Domagoj, et al.
Publicado: (2019) -
Relación entre la amplificación del oncogén C-erbB-2 y parámetros histológicos con sobrevida libre de enfermedad en pacientes con cáncer de mama
por: Rojas-Atencio,Alicia E., et al.
Publicado: (2005) -
Expanding the Disorder-Function Paradigm in the C-Terminal Tails of Erbbs
por: Louise Pinet, et al.
Publicado: (2021) -
Isolated Intraconal Meningioma
por: Mohammad Taher Rajabi, et al.
Publicado: (2021) -
Surgical Management of Intracranial Meningiomas in the Elderly: Early and Long-term Outcomes
por: Czernicki T
Publicado: (2020)